💉 SS-31 – 50 MG / VIAL – 1 VIAL – ZPHC PHARMA

💉 Product Type

Mitochondria-Targeted Peptide / Experimental Regenerative Peptide

💉 Active Ingredient

SS-31 (Elamipretide / Bendavia)

Strength: 50 MG / Vial

Presentation: 1 Vial

💉 Description

SS-31, also known as Elamipretide or Bendavia, is an experimental mitochondria-targeted tetrapeptide studied for its potential role in mitochondrial function, cellular energy production, oxidative stress regulation, and tissue protection.

Unlike peptides that primarily act through conventional cell-surface receptors, SS-31 is designed to selectively interact with the inner mitochondrial membrane, particularly with cardiolipin, an important phospholipid involved in mitochondrial membrane structure and energy production.

By supporting mitochondrial membrane stability and reducing mitochondrial oxidative stress, SS-31 has been investigated across several areas including cellular metabolism, cardiovascular function, skeletal muscle performance, neuroprotection, and age-related mitochondrial dysfunction.

⚙️ Mechanism of Action

• Targets the inner mitochondrial membrane.

• Interacts with cardiolipin, helping stabilize mitochondrial membrane structure.

• May reduce excessive production of reactive oxygen species (ROS).

• Supports mitochondrial electron-transport and energy-production processes.

• Helps maintain mitochondrial membrane integrity and cellular energy homeostasis.

• Has been investigated for its potential protective effects against mitochondrial dysfunction.

🔬 Key Research Benefits

✅ Supports mitochondrial function research

✅ Promotes cellular energy-production pathways

✅ Investigated for oxidative-stress reduction

✅ Supports mitochondrial membrane stability

✅ Studied in cardiovascular and metabolic research

✅ Investigated for skeletal-muscle and exercise-related mitochondrial function

✅ Research interest in neuroprotective and cellular-aging pathways

🧬 Research Applications

SS-31 has been investigated in research involving:

• Mitochondrial dysfunction

• Oxidative stress

• Cardiovascular health

• Skeletal muscle function

• Cellular energy metabolism

• Neuroprotection

• Age-related cellular changes

⚠️ Possible Side Effects

Reported or investigated adverse effects may include:

⚠ Injection-site reactions

⚠ Headache

⚠ Nausea or gastrointestinal discomfort

⚠ Dizziness

⚠ Fatigue

⚠ Local irritation or sensitivity

The long-term safety profile of SS-31 continues to be evaluated because it remains an investigational compound.

⚠️ Precautions

❌ SS-31 is an experimental compound and should not be considered an approved treatment.

❌ Human safety and long-term efficacy have not been fully established.

❌ Use should be limited to appropriate professional or research settings.

❌ Avoid use in pregnancy or breastfeeding unless specifically evaluated by a qualified healthcare professional.

📦 Technical Summary